Literature DB >> 22689802

Imaging features of extramedullary, relapsed, and refractory multiple myeloma involving the liver across treatment with cyclophosphamide, lenalidomide, bortezomib, and dexamethasone.

Sachin S Saboo1, Fiona Fennessy, Lina Benajiba, Jacob Laubach, Kenneth C Anderson, Paul G Richardson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22689802      PMCID： PMC4874151          DOI： 10.1200/JCO.2011.41.1413

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

1.  Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma.

Authors:  K Oshima; Y Kanda; Y Nannya; M Kaneko; T Hamaki; M Suguro; R Yamamoto; A Chizuka; T Matsuyama; N Takezako; A Miwa; A Togawa; H Niino; M Nasu; K Saito; T Morita
Journal:  Am J Hematol       Date:  2001-05       Impact factor: 10.047

Review 2.  Extramedullary disease and targeted therapies for hematological malignancies--is the association real?

Authors:  P Raanani; O Shpilberg; I Ben-Bassat
Journal:  Ann Oncol       Date:  2006-06-21       Impact factor: 32.976

3.  Multiple myeloma presenting with [18F]fluorodeoxyglucose avid liver lesions diagnosed on positron emission tomography scan.

Authors:  Munir Ghesani; Sumina Goel; Seth Cohen; Peter Maslin; Murali Meka; Angela Chang
Journal:  J Clin Oncol       Date:  2007-11-20       Impact factor: 44.544

Review 4.  Advances in imaging and the management of myeloma bone disease.

Authors:  Evangelos Terpos; Lia A Moulopoulos; Meletios A Dimopoulos
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

Review 5.  Multiple myeloma presenting as space-occupying lesions of the liver.

Authors:  R Thiruvengadam; R B Penetrante; H J Goolsby; Y N Silk; Z P Bernstein
Journal:  Cancer       Date:  1990-06-15       Impact factor: 6.860

6.  Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma.

Authors:  K Detweiler Short; S V Rajkumar; D Larson; F Buadi; S Hayman; A Dispenzieri; M Gertz; S Kumar; J Mikhael; V Roy; R A Kyle; M Q Lacy
Journal:  Leukemia       Date:  2011-02-25       Impact factor: 11.528

7.  Multicenter, phase I, dose-escalation trial of lenalidomide plus bortezomib for relapsed and relapsed/refractory multiple myeloma.

Authors:  Paul G Richardson; Edie Weller; Sundar Jagannath; David E Avigan; Melissa Alsina; Robert L Schlossman; Amitabha Mazumder; Nikhil C Munshi; Irene M Ghobrial; Deborah Doss; Diane L Warren; Laura E Lunde; Mary McKenney; Carol Delaney; Constantine S Mitsiades; Teru Hideshima; William Dalton; Robert Knight; Dixie-Lee Esseltine; Kenneth C Anderson
Journal:  J Clin Oncol       Date:  2009-09-28       Impact factor: 44.544

8.  Radiologic manifestations of primary solitary extramedullary and multiple solitary plasmacytomas.

Authors:  Gaik Cheng Ooi; James Chor-Sang Chim; Wing-Yeh Au; Pek-Lan Khong
Journal:  AJR Am J Roentgenol       Date:  2006-03       Impact factor: 3.959

9.  Bortezomib: an effective agent in extramedullary disease in multiple myeloma.

Authors:  Rosiñol Laura; Maria Teresa Cibeira; Carla Uriburu; Sebastián Yantorno; Olga Salamero; Joan Bladé; Emili Montserrat
Journal:  Eur J Haematol       Date:  2006-03-09       Impact factor: 2.997

Review 10.  New drugs for myeloma.

Authors:  Paul G Richardson; Constantine Mitsiades; Robert Schlossman; Nikhil Munshi; Kenneth Anderson
Journal:  Oncologist       Date:  2007-06
View more
  4 in total

1.  Autologous stem cell transplantation in EBV-positive post-renal transplant refractory multiple myeloma: A case report and literature review.

Authors:  Xiaobao Xie; Yan Lin; Yang Cao; Weimin Dong; Wei Wu; Yuandong Zhu; Deliang Liu; Haiqian Li; Qing Li; Weiying Gu
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

2.  Successful treatment with lenalidomide of secondary multiple myeloma with extramedullary liver plasmacytoma in a renal transplant recipient: A case report and review of the literature.

Authors:  Xiaobao Xie; Wei Wu; Yuandong Zhu; Deliang Liu; Weimin Dong; Haiqian Li; Qing Li; Weiying Gu
Journal:  Oncol Lett       Date:  2015-09-18       Impact factor: 2.967

3.  Detection of Extramedullary Multiple Myeloma in Liver by FDG-PET/CT.

Authors:  Dae-Weung Kim; Woo Hyoung Kim; Myoung Hyoun Kim; Keum Ha Choi; Chang Guhn Kim
Journal:  Nucl Med Mol Imaging       Date:  2013-12-24

4.  Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma.

Authors:  Andrew C Tiu; Rashmika Potdar; Vivian Arguello-Gerra; Mark Morginstin
Journal:  Case Rep Hematol       Date:  2018-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.